| Title | Bisphosphonates and osteonecrosis: potential treatment or serious complication? | | Author(s) | Goytia RN, Salama A, Khanuja HS | | Institution | Johns Hopkins Orthopaedics at Good Samaritan Hospital, 5601 Loch Raven Boulevard, Professional Office Building, Suite G-1, Baltimore, MD 21239, USA. | | Source | Orthop Clin North Am 2009 Apr; 40(2):223-34. | | MeSH | Bone Density Conservation Agents
Bone Resorption
Bone and Bones
Diphosphonates
Humans
Osteonecrosis
Risk Factors
| | Abstract | They are commonly used to treat osteoporosis and other diseases that involve osteoclast-mediated bone resorption, including Paget's disease and multiple myeloma. Their use in treating osteonecrosis of the femoral head has been studied and theoretically holds promise. There are complications associated with these medications, however, including the development of osteonecrosis in the jaw. | | Language | eng | | Pub Type(s) | Journal Article
Review
| | PubMed ID | 19358907 |
|
